Rückert, Timo http://orcid.org/0000-0003-1433-1372
Lareau, Caleb A. http://orcid.org/0000-0003-4179-4807
Mashreghi, Mir-Farzin http://orcid.org/0000-0002-8015-6907
Ludwig, Leif S.
Romagnani, Chiara http://orcid.org/0000-0002-5167-7463
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SPP 1937 (RO3565/4-2), SFB TRR241 B02)
Leibniz-Gemeinschaft (Science Campus Chronic Inflammation, Kooperative Exzellenz K259/2019)
European Research Council Horizon Europe - Advanced Grant “MEM-CLONK” Berlin Health Innovations (BHI) - Validation Fund
Berlin Health Innovations (BHI) - Validation Fund
Article History
Received: 28 July 2022
Accepted: 9 September 2022
First Online: 26 October 2022
Competing interests
: T.R. and C.R. are listed as inventors on a patent series covering NKG2C-activating peptides. The other authors declare no competing interests.